Cargando…

Commercial 4-dimensional echocardiography for murine heart volumetric evaluation after myocardial infarction

BACKGROUND: Traditional preclinical echocardiography (ECHO) modalities, including 1-dimensional motion-mode (M-Mode) and 2-dimensional long axis (2D-US), rely on geometric and temporal assumptions about the heart for volumetric measurements. Surgical animal models, such as the mouse coronary artery...

Descripción completa

Detalles Bibliográficos
Autores principales: Rutledge, Cody, Cater, George, McMahon, Brenda, Guo, Lanping, Nouraie, Seyed Mehdi, Wu, Yijen, Villanueva, Flordeliza, Kaufman, Brett A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7068892/
https://www.ncbi.nlm.nih.gov/pubmed/32164714
http://dx.doi.org/10.1186/s12947-020-00191-5
_version_ 1783505665406271488
author Rutledge, Cody
Cater, George
McMahon, Brenda
Guo, Lanping
Nouraie, Seyed Mehdi
Wu, Yijen
Villanueva, Flordeliza
Kaufman, Brett A.
author_facet Rutledge, Cody
Cater, George
McMahon, Brenda
Guo, Lanping
Nouraie, Seyed Mehdi
Wu, Yijen
Villanueva, Flordeliza
Kaufman, Brett A.
author_sort Rutledge, Cody
collection PubMed
description BACKGROUND: Traditional preclinical echocardiography (ECHO) modalities, including 1-dimensional motion-mode (M-Mode) and 2-dimensional long axis (2D-US), rely on geometric and temporal assumptions about the heart for volumetric measurements. Surgical animal models, such as the mouse coronary artery ligation (CAL) model of myocardial infarction, result in morphologic changes that do not fit these geometric assumptions. New ECHO technology, including 4-dimensional ultrasound (4D-US), improves on these traditional models. This paper aims to compare commercially available 4D-US to M-mode and 2D-US in a mouse model of CAL. METHODS: 37 mice underwent CAL surgery, of which 32 survived to a 4 week post-operative time point. ECHO was completed at baseline, 1 week, and 4 weeks after CAL. M-mode, 2D-US, and 4D-US were taken at each time point and evaluated by two separate echocardiographers. At 4 weeks, a subset (n = 12) of mice underwent cardiac magnetic resonance (CMR) imaging to serve as a reference standard. End systolic volume (ESV), end diastolic volume (EDV), and ejection fraction (EF) were compared among imaging modalities. Hearts were also collected for histologic evaluation of scar size (n = 16) and compared to ECHO-derived wall motion severity index (WMSI) and global longitudinal strain as well as gadolinium-enhanced CMR to compare scar assessment modalities. RESULTS: 4D-US provides close agreement of ESV (Bias: -2.55%, LOA: − 61.55 to 66.66) and EF (US Bias: 11.23%, LOA − 43.10 to 102.8) 4 weeks after CAL when compared to CMR, outperforming 2D-US and M-mode estimations. 4D-US has lower inter-user variability as measured by intraclass correlation (ICC) in the evaluation of EDV (0.91) and ESV (0.93) when compared to other modalities. 4D-US also allows for rapid assessment of WMSI, which correlates strongly with infarct size by histology (r = 0.77). CONCLUSION: 4D-US outperforms M-Mode and 2D-US for volumetric analysis 4 weeks after CAL and has higher inter-user reliability. 4D-US allows for rapid calculation of WMSI, which correlates well with histologic scar size.
format Online
Article
Text
id pubmed-7068892
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-70688922020-03-18 Commercial 4-dimensional echocardiography for murine heart volumetric evaluation after myocardial infarction Rutledge, Cody Cater, George McMahon, Brenda Guo, Lanping Nouraie, Seyed Mehdi Wu, Yijen Villanueva, Flordeliza Kaufman, Brett A. Cardiovasc Ultrasound Research BACKGROUND: Traditional preclinical echocardiography (ECHO) modalities, including 1-dimensional motion-mode (M-Mode) and 2-dimensional long axis (2D-US), rely on geometric and temporal assumptions about the heart for volumetric measurements. Surgical animal models, such as the mouse coronary artery ligation (CAL) model of myocardial infarction, result in morphologic changes that do not fit these geometric assumptions. New ECHO technology, including 4-dimensional ultrasound (4D-US), improves on these traditional models. This paper aims to compare commercially available 4D-US to M-mode and 2D-US in a mouse model of CAL. METHODS: 37 mice underwent CAL surgery, of which 32 survived to a 4 week post-operative time point. ECHO was completed at baseline, 1 week, and 4 weeks after CAL. M-mode, 2D-US, and 4D-US were taken at each time point and evaluated by two separate echocardiographers. At 4 weeks, a subset (n = 12) of mice underwent cardiac magnetic resonance (CMR) imaging to serve as a reference standard. End systolic volume (ESV), end diastolic volume (EDV), and ejection fraction (EF) were compared among imaging modalities. Hearts were also collected for histologic evaluation of scar size (n = 16) and compared to ECHO-derived wall motion severity index (WMSI) and global longitudinal strain as well as gadolinium-enhanced CMR to compare scar assessment modalities. RESULTS: 4D-US provides close agreement of ESV (Bias: -2.55%, LOA: − 61.55 to 66.66) and EF (US Bias: 11.23%, LOA − 43.10 to 102.8) 4 weeks after CAL when compared to CMR, outperforming 2D-US and M-mode estimations. 4D-US has lower inter-user variability as measured by intraclass correlation (ICC) in the evaluation of EDV (0.91) and ESV (0.93) when compared to other modalities. 4D-US also allows for rapid assessment of WMSI, which correlates strongly with infarct size by histology (r = 0.77). CONCLUSION: 4D-US outperforms M-Mode and 2D-US for volumetric analysis 4 weeks after CAL and has higher inter-user reliability. 4D-US allows for rapid calculation of WMSI, which correlates well with histologic scar size. BioMed Central 2020-03-12 /pmc/articles/PMC7068892/ /pubmed/32164714 http://dx.doi.org/10.1186/s12947-020-00191-5 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Rutledge, Cody
Cater, George
McMahon, Brenda
Guo, Lanping
Nouraie, Seyed Mehdi
Wu, Yijen
Villanueva, Flordeliza
Kaufman, Brett A.
Commercial 4-dimensional echocardiography for murine heart volumetric evaluation after myocardial infarction
title Commercial 4-dimensional echocardiography for murine heart volumetric evaluation after myocardial infarction
title_full Commercial 4-dimensional echocardiography for murine heart volumetric evaluation after myocardial infarction
title_fullStr Commercial 4-dimensional echocardiography for murine heart volumetric evaluation after myocardial infarction
title_full_unstemmed Commercial 4-dimensional echocardiography for murine heart volumetric evaluation after myocardial infarction
title_short Commercial 4-dimensional echocardiography for murine heart volumetric evaluation after myocardial infarction
title_sort commercial 4-dimensional echocardiography for murine heart volumetric evaluation after myocardial infarction
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7068892/
https://www.ncbi.nlm.nih.gov/pubmed/32164714
http://dx.doi.org/10.1186/s12947-020-00191-5
work_keys_str_mv AT rutledgecody commercial4dimensionalechocardiographyformurineheartvolumetricevaluationaftermyocardialinfarction
AT catergeorge commercial4dimensionalechocardiographyformurineheartvolumetricevaluationaftermyocardialinfarction
AT mcmahonbrenda commercial4dimensionalechocardiographyformurineheartvolumetricevaluationaftermyocardialinfarction
AT guolanping commercial4dimensionalechocardiographyformurineheartvolumetricevaluationaftermyocardialinfarction
AT nouraieseyedmehdi commercial4dimensionalechocardiographyformurineheartvolumetricevaluationaftermyocardialinfarction
AT wuyijen commercial4dimensionalechocardiographyformurineheartvolumetricevaluationaftermyocardialinfarction
AT villanuevaflordeliza commercial4dimensionalechocardiographyformurineheartvolumetricevaluationaftermyocardialinfarction
AT kaufmanbretta commercial4dimensionalechocardiographyformurineheartvolumetricevaluationaftermyocardialinfarction